Phospholine Iodide

   
Google
 
Web NewDrugInformation.com

Phospholine Iodide


Drug - Phospholine Iodide
The trade name of the product as shown on the labeling.

Dosage - FOR SOLUTION; OPHTHALMIC
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Echothiophate Iodide
Multiple ingredients are in alphabetical order.

Strength - 0.06%
The potency of the active ingredient(s), Echothiophate Iodide. May repeat for multiple part products.

Applicant - AYERST
The firm name holding legal responsibility for Phospholine Iodide. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 011963
The FDA assigned number to Phospholine Iodide. Format is nnnnnn.

Product Number - 004
The FDA assigned number to identify Phospholine Iodide. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Phospholine Iodide was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Phospholine Iodide. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Phospholine Iodide is in. Format is RX, OTC, DISCN.

Applicant Full Name - Ayerst Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Phospholine Iodide.

Phospholine Iodide